Emergency department-based testing for xylazine and other novel psychoactive substances in Central Alabama: a feasibility study

Abstract Alabama, like other states in the Deep South, lacks comprehensive testing for novel psychoactive substances (NPS) and adulterants like xylazine, leaving gaps in the detection of drug supply changes. From August 2024 to July 2025, we implemented an active testing approach at an emergency dep...

ver descrição completa

Detalhes bibliográficos

Principais autores:	William Bradford, Daniel Dye, Rebecca Jensen, Reed Bratches, Stacy Marshall, Ellen Eaton, Mary Figgatt, Whitney Taylor, Lauren A Walter, David Goodman-Meza, Stefan Kertesz, Karen S. Scott
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2026-01-01
Colecção:	Harm Reduction Journal
Assuntos:	Xylazine Fentanyl Opioid Cohort Adulterants Alabama
Acesso em linha:	https://doi.org/10.1186/s12954-026-01401-5
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!